CeNeRx BioPharma, Inc.: Series D $4.6M

Posted in I - Series C, Q - 4Q11, R - SOUTH EAST, X - Anxiety, X - CNS, X - Depression, XX - NC

CeNeRx (Cary, NC) a clinical-stage biopharmaceutical company focused on diseases of the central nervous system, depression and anxiety, closed a $4.6M Series D financing. Participants include Aisling Capital, L Capital Partners, Perseus Soros Biopharmaceutical Fund, Omega Funds and Pappas Ventures.

MSI Methylation Sciences, Inc.: Series A $18.2M

Posted in I - Series A, Q - 3Q11, R - INTERNATIONAL, X - CNS, X - Depression

MSI Methylation Sciences (Canada) a preclinical-stage pharmaceutical company focused on depression, closed a $18.2M Series A financing. Participants include Inventages, GrowthWorks and BC Advantage Funds.

Naurex, Inc.: Series A $18M

Posted in I - Series A, Q - 2Q11, R - MID WEST, X - CNS, X - Depression, XX - IL

Naurex (Evanston, IL) a clinical-stage pharmaceutical company focused on depression and other CNS-related disorders, closed a $18M Series A financing. Participants include Adams Street Partners, Latterell Venture Partners, Druid BioVentures, Genesys Capital, PathoCapital, Lundbeck, Takeda Ventures and Shire.

Euthymics Bioscience, Inc.: Seris A $24M

Posted in I - Series A, Q - 3Q10, R - NORTH EAST, X - CNS, X - Depression, XX - MA

Euthymics Bioscience (Cambridge, MA) a clinical-stage small molecule company focused on CNS disorders and depression, closed a $24M Series A financing. Participants include Novartis Venture Fund, Venture Investors, H&Q Capital Management and GBS Venture Partners.

Marinus Pharmaceuticals, Inc.: Series B $20M

Posted in I - Series B, Q - 2Q09, R - NORTH EAST, X - CNS, X - Depression, X - PTSD, X - Seizures, XX - CT

Marinus Pharmaceuticals (Branford, CT) a clinical-stage company focused on reformulation and development of therapeutics for the treatment of CNS, psychiatric and pain disorders, closed a $20M Series B financing. Participants include Canaan Partners, Domain Associates, Sofinnova Ventures and Foundation Medical Partners.

CeNeRx BioPharma, Inc.: Series B $15M

Posted in I - Series B, Q - 4Q08, R - SOUTH EAST, X - Anxiety, X - Depression, X - Epilepsy

CeNeRx BioPharma (Cary, NC) developer of CNS therapeutics for depression, anxiety and
epilepsy, closed a $15M Series B financing. Participants include Aisling Capital, L Capital Partners and Pappas Ventures.

to top of page...